AstraZeneca files for US approval of drug to prevent COVID-19
The treatment, an antibody therapy called AZD7442, had reduced the risk of people developing any COVID-19 symptoms by 77% in a late-stage trial.
said on Tuesday it had submitted a request with U.S. health regulators to grant emergency use authorisation for a new treatment to prevent COVID-19.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
ETPrime stories of the day